New drugs take too long to get to market because of clinical trial bottlenecks. Two cancer doctors built AI-enabled tech to ...

U nder the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical ...

The clinical trial process is broken for a variety of reasons, ranging from the difficulty of designing trial protocols to the cost of running them. But one critical ...

When Katie Doble was diagnosed with a rare cancer, she was given 16 months to live. Clinical trials gave her a second chance.

Ken Wallace, MBA, is president, Clinical Trial Marketing Communications (CTMC), and through a joint venture, vice president of operations, Integrated Clinical Trial Services (ICTS).

Breaking Down the Clinical Trial Process. Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer.

With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process. [Adobe Stock ...

A four-year-old London startup backed by Peter Thiel has raised a $55 million Series B round as it sets about “fixing the broken clinical trial industry.” The announcement comes as artificial ...

AI-driven text analytics can revolutionise the clinical trial process by improving data collection and analysis in the biopharma industry. Learn how this technology can enhance efficiency and ...

The development of new medications is a long, complex, and costly process. Productivity—how efficiently a drug developer creates value from their investment—is key to success, yet it often ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his life by 30 years.

In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions.